Summary

Johne’s Disease Diagnostics Market Growth & Trends

The global Johne’s disease diagnostics market size is estimated to reach USD 994.07 million by 2030, registering to grow at a CAGR of 6.21% from 2025 to 2030 according to a new report by Grand View Research, Inc. Growing awareness about Johne’s disease increases the number of diagnostic tests in animals, contributing to market growth. Moreover, the increasing prevalence of zoonotic diseases is another factor driving the market for Johne’s disease diagnostics. The increasing cattle population or livestock population is a major factor responsible for market growth. According to NCBI, the global cow population might grow from 1.5 billion to 2.6 billion between 2000 and 2050, while the global goat and sheep population could grow from 1.7 billion to 2.7 billion.

The COVID-19 pandemic has had a major impact on the global population, as well as companies and sectors in a variety of ways. To deal with the dilemma, the healthcare profession has been forced to develop both therapeutic and preventative measures. The pandemic has had a wide-ranging impact on many aspects of life, including the veterinary sector, necessitating a delicate balancing act between animal welfare and public health. Johne’s disease diagnostics sector, like other markets, has been severely impacted. Supply chain disruptions, poor demand, and operational challenges owing to shifting laws and restrictions are some of the key negative effects of COVID-19 on the market.

Furthermore, factors driving the market include the presence of numerous animal health and diagnostics companies and a rise in veterinary healthcare expenditure which is expected to accelerate the growth of the market. Furthermore, the presence of healthcare programs and a rise in the number of initiatives to promote animal health are factors anticipated to increase the growth potential in this region. Efficient measures undertaken by animal welfare organizations in case of an emergency or sudden disease outbreak are also expected to contribute to market growth across the globe. Moreover, well-developed infrastructure and high R&D spending in the region are factors anticipated to boost the market.

Many new diagnostic tests are expected to be introduced in the market over the next few years. Local players and online sales of these devices and kits present major sources of competition. Existing players are enhancing their portfolios with technologically advanced products and are widening their geographic reach by acquiring smaller local players. For instance, in July 2020, VMRD, Inc. received USDA approval for the testing of goat serum on its Johne’s Antibody Test Kit. This new development complemented the USDA's existing licensing for bovine serum and milk samples, for which, this test can be widely utilized in laboratories throughout the U.S. and the world.

Johne’s Disease Diagnostics Market Report Highlights

• The cattle segment dominated the market and accounted for the largest revenue share of more than 87% in 2024.

• Veterinary hospitals and clinics dominated the market with the largest revenue share of over 53% in 2024. Hospitals and clinics have the infrastructure to conduct various diagnostic tests, such as ELISA and PCR, that detect Johne’s disease.

• The PCR segment dominated the market and accounted for over 36.0% in 2024. The swift acceptance of testing and diagnostic technologies, as well as the increase in the livestock population, are the primary drivers anticipated to fuel the segment growth.

• North America Johne’s disease diagnostics market dominated the global market and accounted for the largest revenue share of more than 32.0% in 2024.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Johne’s Disease Diagnostics Industry Outlook
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Livestock Population
3.2.1.2. Johne’s Disease Eradication Program
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of Awareness
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Johne’s Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Product Pricing Analysis
3.3.5. Estimated Animal Population, by key species & key countries, 2024
3.3.6. COVID-19 Impact Analysis
Chapter 4. Johne’s Disease Diagnostics Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Johne’s Disease Diagnostics Market: Animal type Movement Analysis
4.3. Global Johne’s Disease Diagnostics Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
4.4. Cattle
4.4.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Goat
4.5.1. Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Sheep
4.6.1. Sheep Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Johne’s Disease Diagnostics Market: Test Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Johne’s Disease Diagnostics Market: test type Movement Analysis
5.3. Global Johne’s Disease Diagnostics Market Size & Trend Analysis, by test type, 2018 to 2030 (USD Million)
5.3.1. ELISA
5.3.1.1. ELISA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. PCR
5.3.2.1. PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. AGID
5.3.3.1. AGID Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Johne’s Disease Diagnostics Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Johne’s Disease Diagnostics Market: End Use Movement Analysis
6.3. Global Johne’s Disease Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.3.1. Veterinary Hospitals & clinics
6.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Others
6.3.2.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Johne’s Disease Diagnostics Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Johne’s Disease Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
7.3. Regional Outlook
7.4. North America
7.4.1. North America Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. U.S. Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Canada Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Mexico Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. UK Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Germany Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. France Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Italy Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Spain Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Denmark Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Sweden Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Norway Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Japan Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. China Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. India Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Australia Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. South Korea Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Thailand Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Brazil Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Argentina Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. South Africa Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Saudi Arabia Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. UAE Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Kuwait Johne’s Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heap Map Analysis
8.3. Company Profiles
8.3.1. Thermo Fisher Scientific, Inc.
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. PBD Biotech
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Zoetis
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. IDEXX Laboratories.
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. IDVET
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. VMRD Inc.
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Biomeriux SA.
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. INDICAL BIOSCIENCE GmbH
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. MV Diagnostics (Sure Farm Ltd)
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Tetracore, Inc.
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.4. Strategy Mapping
8.4.1. Mergers & Acquisitions
8.4.2. Partnerships & Collaborations
8.4.3. Service Launch
8.4.4. Expansions
8.4.5. Others
8.5. List of Other Key Players